Liz Parrish Is Patient Zero in Her Own Anti-Aging Experiment

Elizabeth (Liz) Parrish is the CEO of BioViva, a biotechnology company that focuses on developing gene therapies, and other regenerative therapies, to intervene with human aging. Last September, Parrish added an interesting line to her job description: patient zero for two anti-aging therapies that the company is researching. Parrish is receiving two kinds of injections, which are administered outside the United States: a myostatin inhibitor, which is expected to prevent age-associated